{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:49:25Z","timestamp":1794566965559,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2729-6","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T15:17:46Z","timestamp":1506957466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Group B streptococcus (GBS) is an important pathogen in human disease- but what about in cystic fibrosis?"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1798-2218","authenticated-orcid":false,"given":"Kate","family":"Skolnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina S.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey R.","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Parkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,2]]},"reference":[{"issue":"5","key":"2729_CR1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4187\/aarc0427","volume":"54","author":"FA Ratjen","year":"2009","unstructured":"Ratjen FA. Cystic fibrosis: pathogenesis and future treatment strategies. Respir Care. 2009;54(5):595\u2013605.","journal-title":"Respir Care"},{"issue":"5","key":"2729_CR2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0092-8674(00)80570-X","volume":"96","author":"WB Guggino","year":"1999","unstructured":"Guggino WB. Cystic fibrosis and the salt controversy. Cell. 1999;96(5):607\u201310.","journal-title":"Cell"},{"issue":"Suppl 1","key":"2729_CR3","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1513\/AnnalsATS.201306-159MG","volume":"11","author":"MG Surette","year":"2014","unstructured":"Surette MG. The cystic fibrosis lung microbiome. Ann Am Thorac Soc. 2014;11(Suppl 1):S61\u20135.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"2729_CR4","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0022-3476(05)82653-8","volume":"116","author":"E Kerem","year":"1990","unstructured":"Kerem E, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas Aeruginosa. J Pediatr. 1990;116(5):714\u20139.","journal-title":"J Pediatr"},{"issue":"12","key":"2729_CR5","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1128\/JCM.42.12.5537-5541.2004","volume":"42","author":"B Fauroux","year":"2004","unstructured":"Fauroux B, Hart N, Belfar S, Boule M, Tillous-Borde I, Bonnet D, et al. Burkholderia cepacia is associated with pulmonary hypertension and increased mortality among cystic fibrosis patients. J Clin Microbiol. 2004;42(12):5537\u201341.","journal-title":"J Clin Microbiol"},{"issue":"8","key":"2729_CR6","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.200802-327OC","volume":"178","author":"EC Dasenbrook","year":"2008","unstructured":"Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP. Persistentmethicillin-resistant Staphylococcus Aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med. 2008;178(8):814\u201321.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2729_CR7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcf.2016.03.001","volume":"15","author":"MD Parkins","year":"2016","unstructured":"Parkins MD, Surette MG. Understanding the natural history and clinical implications of airways infections in CF-moving beyond the classics. J Cyst Fibros. 2016;15(3):270\u20131.","journal-title":"J Cyst Fibros"},{"issue":"8","key":"2729_CR8","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1128\/JCM.43.8.3938-3943.2005","volume":"43","author":"R Chiron","year":"2005","unstructured":"Chiron R, Marchandin H, Counil F, Jumas-Bilak E, Freydiere AM, Bellon G, Husson MO, Turck D, Bremont F, Chabanon G, Segonds C. Clinical and microbiological features of Inquilinus sp. isolates from five patients with cystic fibrosis. J Clin Microbiol. 2005;43(8):3938\u201343.","journal-title":"J Clin Microbiol"},{"key":"2729_CR9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s12879-015-1327-8","volume":"15","author":"N Degand","year":"2015","unstructured":"Degand N, Lotte R, Deconde le Butor C, Segonds C, Thouverez M, Ferroni A, Vallier C, Mely L, Carrere J. Epidemic spread of Pandoraea pulmonicola in a cystic fibrosis center. BMC Infect Dis. 2015;15:583.","journal-title":"BMC Infect Dis"},{"key":"2729_CR10","doi-asserted-by":"crossref","unstructured":"A. Perry FKG, M. Brodlie, M. Ni Chroinin, D. Mullane, B. Plant, G. McElvaney, C. Gunaratnam, K. Schaffer, J. Egan, D. Kenna, C. Perry, J.F. Turton, E. Mahenthiralingham, M.M. Hannan. Ralstonia mannitolilytica \u2013 an emerging threat in cystic fibrosis and lung transplantation. Paper presented at: European Cystic Fibrosis Conference 2015.","DOI":"10.1016\/S1569-1993(15)30236-8"},{"key":"2729_CR11","unstructured":"Cystic Fibrosis Foundation Registry. Report. 2013. Accessed from: https:\/\/www.cff.org\/About-Us\/Assets\/2013-Annual-Report\/ ."},{"key":"2729_CR12","unstructured":"The Canadian cystic fibrosis registry 2013 annual data report. Accessed from: http:\/\/www.cysticfibrosis.ca\/uploads\/cf%20care\/Canadian-CF-Registry-2013-FINAL.pdf ."},{"key":"2729_CR13","unstructured":"Australian Cystic Fibrosis Data 2014 Registry. Accessed from: https:\/\/www.cysticfibrosis.org.au\/media\/wysiwyg\/CF-Australia\/medical-documents\/CFA_DataRegistryReport_2014_Final.pdf ."},{"key":"2729_CR14","unstructured":"European Cystic Fibrosis Society 2013 Registry. Accessed from: https:\/\/www.ecfs.eu\/sites\/default\/files\/general-content-files\/working-groups\/ecfs-patient-registry\/ECFSPR_Report2013_02.2016.pdf ."},{"key":"2729_CR15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12890-015-0157-1","volume":"15","author":"K Skolnik","year":"2015","unstructured":"Skolnik K, Nguyen A, Somayaji R, Thornton CS, Waddell B, Surette MG, et al. Clinical implications and characterization of group a streptococcus infections in adults with cystic fibrosis. BMC Pulm Med. 2015;15:161.","journal-title":"BMC Pulm Med"},{"issue":"20","key":"2729_CR16","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1128\/JB.00429-15","volume":"197","author":"A Almeida","year":"2015","unstructured":"Almeida A, Villain A, Joubrel C, Touak G, Sauvage E, Rosinski-Chupin I, et al. Whole-genome comparison uncovers genomic mutations between group B streptococci sampled from infected newborns and their mothers. J Bacteriol. 2015;197(20):3354\u201366.","journal-title":"J Bacteriol"},{"issue":"17","key":"2729_CR17","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.299.17.2056","volume":"299","author":"CR Phares","year":"2008","unstructured":"Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008;299(17):2056\u201365.","journal-title":"JAMA"},{"issue":"6","key":"2729_CR18","first-page":"25","volume":"41","author":"KM Zangwill","year":"1992","unstructured":"Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ. 1992;41(6):25\u201332.","journal-title":"MMWR CDC Surveill Summ"},{"issue":"10","key":"2729_CR19","doi-asserted-by":"crossref","first-page":"e007976","DOI":"10.1136\/bmjopen-2015-007976","volume":"5","author":"A Kalin","year":"2015","unstructured":"Kalin A, Acosta C, Kurinczuk JJ, Brocklehurst P, Knight M. Severe sepsis in women with group B streptococcus in pregnancy: an exploratory UK national case-control study. BMJ Open. 2015;5(10):e007976.","journal-title":"BMJ Open"},{"issue":"6","key":"2729_CR20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.7326\/0003-4819-123-6-199509150-00003","volume":"123","author":"LA Jackson","year":"1995","unstructured":"Jackson LA, Hilsdon R, Farley MM, Harrison LH, Reingold AL, Plikaytis BD, et al. Risk factors for group B streptococcal disease in adults. Ann Intern Med. 1995;123(6):415\u201320.","journal-title":"Ann Intern Med"},{"issue":"6","key":"2729_CR21","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/clinids\/8.6.912","volume":"8","author":"A Verghese","year":"1986","unstructured":"Verghese A, Mireault K, Arbeit RD. Group B streptococcal bacteremia in men. Rev Infect Dis. 1986;8(6):912\u20137.","journal-title":"Rev Infect Dis"},{"issue":"25","key":"2729_CR22","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199306243282503","volume":"328","author":"MM Farley","year":"1993","unstructured":"Farley MM, Harvey RC, Stull T, et al. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med. 1993;328(25):1807.","journal-title":"N Engl J Med"},{"key":"2729_CR23","first-page":"1","volume":"4","author":"V Eickel","year":"2000","unstructured":"Eickel V, Kahl B, Reinisch B, et al. Emergence of respiratory Streptococcus agalactiae in cystic fibrosis patients. PLoS One. 2000;4:1\u20137.","journal-title":"PLoS One"},{"key":"2729_CR24","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/JCM.30.10.2740-2742.1992","volume":"30","author":"GV Doern","year":"1992","unstructured":"Doern GV, Brogden-Torres B. Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol. 1992;30:2740\u20132.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"2729_CR25","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.pcl.2016.04.004","volume":"63","author":"M Rosenfeld","year":"2016","unstructured":"Rosenfeld M, Sontag MK, Ren CL. Cystic fibrosis diagnosis and newborn screening. Pediatr Clin N Am. 2016;63(4):599\u2013615.","journal-title":"Pediatr Clin N Am"},{"issue":"10","key":"2729_CR26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","volume":"331","author":"HJ Fuchs","year":"1994","unstructured":"Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The pulmozyme study group. N Engl J Med. 1994;331(10):637\u201342.","journal-title":"N Engl J Med"},{"key":"2729_CR27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12879-015-0856-5","volume":"15","author":"JC Lam","year":"2015","unstructured":"Lam JC, Somayaji R, Surette MG, Rabin HR, Parkins MD. Reduction in Pseudomonas Aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response. BMC Infect Dis. 2015;15:145.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2729_CR28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","volume":"2","author":"TW Lee","year":"2003","unstructured":"Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros. 2003;2(1):29\u201334.","journal-title":"J Cyst Fibros"},{"issue":"5","key":"2729_CR29","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1164\/rccm.201009-1392OC","volume":"183","author":"V Waters","year":"2011","unstructured":"Waters V, Yau Y, Prasad S, Lu A, Atenafu E, Crandall I, et al. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. Am J Respir Crit Care Med. 2011;183(5):635\u201340.","journal-title":"Am J Respir Crit Care Med"},{"key":"2729_CR30","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1128\/JCM.00414-10","volume":"48","author":"CD Sibley","year":"2010","unstructured":"Sibley CD, Sibley KA, Leong TA, Grinwis ME, Parkins MD, Rabin HR, Surette MG. The Streptococcus Milleri population of a cystic fibrosis clinic reveals patient specificity and intraspecies diversity. J Clin Microbiol. 2010;48:2592\u20134.","journal-title":"J Clin Microbiol"},{"key":"2729_CR31","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/JCM.38.6.2141-2149.2000","volume":"38","author":"KL Bartie","year":"2000","unstructured":"Bartie KL, Wilson MJ, Williams DW, Lewis MA. Macrorestriction fingerprinting of \"Streptococcus Milleri\" group bacteria by pulsed-field gel electrophoresis. J Clin Microbiol. 2000;38:2141\u20139.","journal-title":"J Clin Microbiol"},{"key":"2729_CR32","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12890-015-0041-z","volume":"15","author":"CS Thornton","year":"2015","unstructured":"Thornton CS, Brown EL, Alcantara J, Rabin HR, Parkins MD. Prevalence and impact of Streptococcus Pneumoniae in adult cystic fibrosis patients: a retrospective chart review and capsular serotyping study. BMC Pulm Med. 2015;15:49.","journal-title":"BMC Pulm Med"},{"key":"2729_CR33","unstructured":"CLSI. Performance standards for antimicrobial disk susceptibility tests; approved standard-tenth edition, CLSI document M02-A10. 2009. Clinical and Laboratory Standards Institute."},{"key":"2729_CR34","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/514631","volume":"27","author":"JL Burns","year":"1998","unstructured":"Burns JL, Emerson J, Stapp JR, Yim DL, Krzewinski J, et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin Infect Dis. 1998;27:158\u201363.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2729_CR35","doi-asserted-by":"crossref","first-page":"e1139","DOI":"10.1542\/peds.2005-2481","volume":"117","author":"K Fluegge","year":"2006","unstructured":"Fluegge K, Siedler A, Heinrich B, Schulte-Moenting J, Moennig MJ, Bartels DB, et al. Incidence and clinical presentation of invasive neonatal group B streptococcal infections in Germany. Pediatrics. 2006;117(6):e1139\u201345.","journal-title":"Pediatrics"},{"issue":"1","key":"2729_CR36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijmm.2005.11.001","volume":"296","author":"N Brimil","year":"2006","unstructured":"Brimil N, Barthell E, Heindrichs U, Kuhn M, Lutticken R, Spellerberg B. Epidemiology of Streptococcus agalactiae colonization in Germany. Int J Med Microbiol. 2006;296(1):39\u201344.","journal-title":"Int J Med Microbiol"},{"key":"2729_CR37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12887-015-0460-2","volume":"15","author":"L Rivera","year":"2015","unstructured":"Rivera L, Saez-Llorens X, Feris-Iglesias J, Ip M, Saha S, Adrian PV, et al. Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study. BMC Pediatr. 2015;15:143.","journal-title":"BMC Pediatr"},{"issue":"6","key":"2729_CR38","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00006454-199806000-00013","volume":"17","author":"BJ Stoll","year":"1998","unstructured":"Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J. 1998;17(6):499\u2013503.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"2729_CR39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1155\/2012\/876103","volume":"23","author":"D Church","year":"2012","unstructured":"Church D, Carson J, Gregson D. Point prevalence study of antibiotic susceptibility of genital group B streptococcus isolated from near-term pregnant women in Calgary, Alberta. Can J Infect Dis Med Microbiol. 2012;23(3):121\u20134.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"7","key":"2729_CR40","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1128\/AAC.01845-09","volume":"54","author":"ME Grinwis","year":"2010","unstructured":"Grinwis ME, Sibley CD, Parkins MD, Eshaghurshan CS, Rabin HR, Surette MG. Macrolide and clindamycin resistance in Streptococcus Milleri group isolates from the Airways of Cystic Fibrosis Patients. Antimicrob Agents Chemother. 2010;54(7):2823\u20139. https:\/\/doi.org\/10.1128\/AAC.01845-09 .","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2729-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,18]],"date-time":"2020-10-18T15:50:08Z","timestamp":1603036208000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2729-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,2]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2729"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2729-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,2]]},"article-number":"660"}}